Brief: Editas Medicine Q4 Net Income USD -5.62 Million Vs. IBES Estimate USD -24.3 Million
09/03/2026 11:00
Mar 09 (Reuters) - Editas Medicine Q4 operating expenses USD 32.496 million. Q4 operating income USD -7.755 million Q4 basic EPS USD -0.06 Q4 EPS USD -0.06 Q4 collaboration and other research and development revenue USD 24.7 million
Recent news on Editas Medicine
See all newsEditas Medicine, Inc. reports results for the quarter ended June 30 - Earnings Summary
Editas Medicine, Inc. expected to post a loss of 27 cents a share - Earnings Preview
Editas Medicine Q2 net loss narrows and beats estimates
Brief: Editas Medicine Q2 Net Income USD -18.23 Million Vs. IBES Estimate USD -27 Million
Editas Medicine down after $125 mln stock-and-warrants offering